Gastrointestinal infections can present with a broad and overlapping range of clinical manifestations, making timely identification of the causative pathogen a critical component of patient management. Rapid multiplex PCR testing has significantly enhanced the diagnostic approach by enabling the simultaneous detection of multiple clinically relevant pathogens from a single specimen.

In this webinar, leading clinical experts will discuss the clinical utility of syndromic molecular testing in gastrointestinal infections, focusing on how rapid and comprehensive pathogen detection can inform clinical decision-making.
The discussion will include the detection of clinically significant pathogens such as Shiga toxin-producing E. coli (STEC) stx1/stx2, and the potential role of rapid molecular results in supporting timely, targeted management. Particular attention will be given to challenging patient populations, including paediatric and critically ill patients, where rapid diagnostic information is especially valuable.